In plain words
In most of the small, short trials here, grape seed extract lowered blood signs of oxidative stress or raised the body's own antioxidants. Two of the seven trials found no difference from placebo on what they measured.
The short answer
Five of seven randomized trials point toward lower oxidative stress: Vigna (24 smokers, 300 mg daily, 4 weeks), Kar (32 people with diabetes, 600 mg daily, 4 weeks), Razavi (52 adults, 200 mg daily, 8 weeks), Taghizadeh (40 athletes, 300 mg twice daily, 8 weeks) and Nuttall (20 volunteers, two capsules containing 300 mg daily, 5 days). Two found no difference from placebo: Preuss (40 adults, 100 mg twice daily, 2 months) and Mellen (50 people, 1,300 mg muscadine seed daily, 4 weeks). Certainty is low because the trials are small and short, and they measured different markers.
Where the evidence sits
Markers improved
No difference
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Vigna et al., 2003 | Lower TBARS | Randomized crossover | 24 | 300 mg/day, 4 weeks | Not in ledger |
| Kar et al., 2009 | Glutathione rose | Randomized | 32 | 600 mg/day, 4 weeks | Not in ledger |
| Razavi et al., 2013 | Lower oxidized LDL | Randomized crossover | 52 | 200 mg/day, 8 weeks | Not in ledger |
| Taghizadeh et al., 2016 | Glutathione rose | Randomized | 40 | 300 mg twice daily, 8 weeks | Not in ledger |
| Nuttall et al., 1998 | Antioxidant capacity rose | Randomized crossover | 20 | Two capsules containing 300 mg daily, 5 days | Not in ledger |
| Preuss et al., 2000 | No difference | Randomized | 40 | 100 mg twice daily, 2 months | Not in ledger |
| Mellen et al., 2010 | Not significant | Record describing a randomized trial | 50 | 1,300 mg daily, 4 weeks | Not in ledger |
Lower TBARS
Glutathione rose
Lower oxidized LDL
Glutathione rose
Antioxidant capacity rose
No difference
Not significant
Which trials found a change?
Vigna and colleagues (2003) gave 24 male heavy smokers 300 mg a day or placebo for 4 weeks; LP is their extract group:
thiobarbituric acid reactive substances (TBARS) concentration was significantly reduced in subjects taking LP
Kar and colleagues (2009) found whole blood glutathione rose in 32 people with type 2 diabetes on 600 mg a day for 4 weeks, but not on placebo. Razavi and colleagues (2013) found lower oxidized LDL in 52 adults with mildly raised blood fats on 200 mg a day for 8 weeks. Taghizadeh and colleagues (2016) found glutathione higher and malondialdehyde lower than placebo in 40 volleyball players on 300 mg twice a day for 8 weeks, with total antioxidant capacity unchanged. Nuttall and colleagues (1998) found total antioxidant capacity rose in 20 young volunteers taking two capsules containing 300 mg daily for 5 days.
Which trials found no difference?
Preuss and colleagues (2000) compared groups of 40 adults taking 100 mg twice a day or not for two months:
no statistically significant differences were seen in the levels of autoantibodies to oxidized LDL (Ox-LDL)
A Europe PMC record describes Mellen and colleagues' (2010) randomized trial of 1,300 mg muscadine grape seed daily for 4 weeks in 50 people with or at risk for cardiovascular disease; oxidation markers did not change significantly.
What do the pooled analyses add?
A meta-analysis by Foshati and colleagues (2021) found lower malondialdehyde and oxidized LDL and a marginal rise in total antioxidant capacity, a pooled estimate that may include the trials above.
Sarkhosh-Khorasani and colleagues (2021) combined several grape products in a pooled estimate that may include the trials above, and found total antioxidant capacity rose, but:
it had no significant impact on other oxidative stress biomarkers.
Why the sources disagree
Each trial measured a different marker: TBARS, glutathione, oxidized LDL, antibodies to oxidized LDL or total antioxidant capacity. Total antioxidant capacity splits most: it rose in Nuttall's trial and in Sarkhosh-Khorasani's pooled analysis, not in Taghizadeh's trial, and only marginally in Foshati's; both pooled estimates may include the trials above. Mellen's trial used muscadine seed, and Sarkhosh-Khorasani pooled several grape products. People ranged from young volunteers and athletes to smokers and people with diabetes. The ledger has no funding for any of these studies.
What would settle it
An independent, pre-registered trial randomizing 200 adults to 300 mg of grape seed extract a day or placebo for 12 weeks, with plasma malondialdehyde as the single primary outcome and glutathione, oxidized LDL and total antioxidant capacity as secondary outcomes, all compared against placebo. A matching result from a second research group would raise certainty from low to moderate.
How this page was made
The 9 sources are seven randomized trials and two meta-analyses, pooled estimates that may include the trials above, from a literature search of PubMed and Europe PMC records; animal studies from the search were left out. Every claim was copied word for word from its source into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
Changelog: 4 Oct 2026, first version, 9 sources.